PDCD1 and autoimmune disease: The recent success of cancer immunotherapies targeting PD-1 and the development of autoimmune diseases as their immune related adverse events revealed that PD-1 plays critical roles in the regulation of T cells specific to self antigens as well as tumor-associated antigens in humans.